2nd Quarter - Report

EPILEPSY FOUNDATION for EPILEPSY FOUNDATION

Firm
Client
Income
—
Expenses
$100,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Civil Rights/Civil Liberties CIV

-H.R. 1549, Air Carrier Access Amendments Act, support passage to make air travel more accessible for people with disabilities

LobbyistCovered position, as disclosed
RACHEL PATTERSON —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1549 (116th)

Health Issues HCR

-Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses (CMS-4180-P), oppose weakening of Medicares Six Protected Classes and urge proposed rule to be rescinded -S. 691, Medicare Extra Rx HELP Act, support passage -H.R. 2279, Safe Step Act, support passage -H.R. 1839, Medicaid Services Investment and Accountability Act, support passage of the ACE Kids Act, reauthorization of Money Follows the Person and extension of spousal impoverishment protections - H.R. 2035 / S. 995, Lifespan Respite Care Reauthorization Act, support passage -HR 1385, SAVE Act, support passage -HR 1386, ENROLL Act, support passage -HR 1425, State Health Care Premium Reduction Act, support passage -HR 987, MORE Health Education Act, support passage -HR 986/S. 466, Protecting Americans with Preexisting Conditions Act, support passage -HR 1010, support passage -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -Regulation of products containing cannabis or cannabis-derived compounds -Support reauthorization of the Patient-Centered Outcomes Research Institute (PCORI)

LobbyistCovered position, as disclosed
RACHEL PATTERSON —
ABBEY ROUDEBUSH —
LAURA WEIDNER —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 1028 (116th), H.R. 712 (116th), H.R. 1425 (116th), S. 691 (116th), H.R. 1010 (116th), H.R. 127 (116th), H.R. 1385 (116th), H.R. 1839 (116th), H.R. 986 (116th), H.R. 2093 (116th), H.R. 1386 (116th), S. 995 (116th), S. 466 (116th), H.R. 2279 (116th), H.R. 2035 (116th), H.R. 987 (116th)

Budget/Appropriations BUD

-FY 2020 Labor, Health and Human Services and Education Appropriations Act, support $11.5 million for the Centers for Disease Controls National Center for Chronic Disease Prevention and Health Promotion; $41.6 billion for the National Institutes of Health; $8.56 billion for the Health Resources & Services Administrations (HRSA) discretionary budget authority; $46 million for the Agency for Healthcare Research and Quality (AHRQ); support $20 million for the Lifespan Respite Care Program; and a $1.7 billion increase over 2019 levels for the Individuals with Disabilities Education Act. -H.R. 2968, FY Defense Appropriations Act, support continued funding for the Congressionally Directed Medical Research Program (CDMRP).

LobbyistCovered position, as disclosed
RACHEL PATTERSON —
ABBEY ROUDEBUSH —
LAURA WEIDNER —

Contacted: SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2968 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.